Syros Pharmaceuticals Inc... (SYRS)
0.08
-0.06 (-44.13%)
At close: Mar 03, 2025, 3:59 PM
0.08
-3.43%
Pre-market: Mar 04, 2025, 07:52 AM EST
Syros Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -164.57M | -94.65M | -86.56M | -84.04M | -75.44M | -62.28M | -54.01M | -47.74M | -29.82M | -13.43M | -8.66M |
| Depreciation & Amortization | 2.25M | 2.97M | 3.02M | 3.04M | 2.72M | 1.6M | 1.53M | 1.27M | 602K | 258K | 170K |
| Stock-Based Compensation | 10.43M | 11.41M | 10.35M | 10.94M | 9.84M | 6.61M | 4.42M | 4.23M | 3.23M | 937K | 821K |
| Other Working Capital | -1.77M | -8.28M | -12.64M | -6.35M | 19.54M | 13.5M | -870K | -284K | 914K | -67K | 86K |
| Other Non-Cash Items | 37.13M | -37.27M | 706K | 2.32M | 7.24M | -642K | -102K | 10K | 17K | 334K | 394K |
| Deferred Income Tax | n/a | n/a | -16.46M | 326K | -1.13M | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 5.05M | -5.52M | -10.6M | 10.05M | -3.48M | 14.39M | 3.44M | 1.69M | 2.94M | 267K | 86K |
| Operating Cash Flow | -109.71M | -123.06M | -99.54M | -57.36M | -60.25M | -40.31M | -44.73M | -40.54M | -23.03M | -11.97M | -7.19M |
| Capital Expenditures | -272K | -1.24M | -1.25M | -3.34M | -12.64M | -1.38M | -821K | -2.32M | -1.18M | -201K | -878K |
| Acquisitions | n/a | n/a | n/a | n/a | 110K | 9K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -50.97M | n/a | -51.41M | n/a | -108.21M | -96.77M | -41.77M | -25.02M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 87.02M | 68.43M | n/a | 50M | 109M | 87.5M | 27M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 1.56M | 68.43M | -51.41M | 50M | 904K | 9K | -14.77M | -25.02M | n/a | n/a | n/a |
| Investing Cash Flow | 37.34M | 67.19M | -52.65M | 46.66M | -11.73M | -10.64M | -15.59M | -27.34M | -1.18M | -201K | -878K |
| Debt Repayment | -65K | -291K | -265K | 39.38M | -205K | -50K | -168K | -135K | -50K | n/a | n/a |
| Common Stock Repurchased | n/a | -81K | n/a | n/a | n/a | n/a | n/a | n/a | -620K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 257K | 11.66M | 439K | 1.3M | 5.01M | 626K | 1.8M | 40.21M | 392K | 137.51M | 10.04M |
| Financial Cash Flow | 43.46M | 131.04M | 70.51M | 142.95M | 65.99M | 69.08M | 33.94M | 90.56M | -278K | 68.76M | 10.04M |
| Net Cash Flow | -28.91M | 75.17M | -81.68M | 132.25M | -6M | 18.13M | -26.38M | 22.68M | -24.48M | 56.59M | 1.97M |
| Free Cash Flow | -109.98M | -124.31M | -100.78M | -60.7M | -72.89M | -41.7M | -45.55M | -42.86M | -24.21M | -12.17M | -8.07M |